Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2025 Earnings Call Transcript February 26, 2026
Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $0.2601, expectations were $0.24.
Operator: Good morning — good afternoon, ladies and gentlemen. My name is Sherry, and I will be your conference call operator today. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the conference over to Mariann Ohanesian, Senior Director of IR for Puma...
